Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Nick Barkham"'
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3373-3377 (2020)
Abstract Statin‐induced autoimmune necrotizing myositis is a rare but important cause muscle weakness. Withdrawal of the statin and steroid treatment alone may be insufficient treatment for SIANM. Targeted immunosuppression may be needed and can be
Externí odkaz:
https://doaj.org/article/c3d59333f3ed4a60a500e773fffbf60e
Publikováno v:
Clinical Case Reports, Vol 10, Iss 1, Pp n/a-n/a (2022)
Abstract The COVID‐19 pandemic highlighted the benefits of subcutaneous (SC) administration for healthcare systems. The first SC infliximab, CT‐P13 SC, was safe and effective for the treatment of psoriatic arthritis. Observed patient preferences
Externí odkaz:
https://doaj.org/article/4ebba21ea94f400496f04a2c51e3f57c
Publikováno v:
Clinical Case Reports, Vol 10, Iss 1, Pp n/a-n/a (2022)
Abstract The COVID‐19 pandemic emphasized the utility of subcutaneous (SC) biologics for pressured healthcare systems. The first SC form of infliximab, CT‐P13 SC, provided safe and effective treatment for ankylosing spondylitis in our case series
Externí odkaz:
https://doaj.org/article/6ca262fd3e3545b3a1ec3071392bec7a
Autor:
Natasha Cox, Sabrina R Raizada, Nick Barkham, Srinivasan Venkatachalam, Tom P Sheeran, Tochukwu Adizie, Hem Sapkota, Ian C Scott, Sara Muller, James Bateman
Publikováno v:
Rheumatology Advances in Practice. 7
Objective The aim was to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic and stringent social isolation measures on patients with rheumatic disease (RD) from the beginning of the pandemic (April 2020). Methods In this UK-based
Autor:
Adeola Ajibade, Haridha Pandian, Nibha Jain, Latika Gupta, Ramasharan Laxminarayan, Arumugam Moorthy, Roshan Amarasena, Natasha Cox, Hem Sapkota, Girish Kakade, Srinivasa Elamanchi, Athiveeraramapandian Prabu, Elaf Al-Samaraaie, Nick Barkham
Publikováno v:
Rheumatology Advances in Practice. 7
Autor:
Sabrina Raizada, Tom Sheeran, Natasha Cleaton, Tochukwu Adizie, Hem Raj Sapkota, James Bateman, Srinivasan Venkatachalam, Baldev M Singh, Nick Barkham
Publikováno v:
Rheumatology International
Objectives We sought to gain insight into the prevalence of COVID-19 and the impact stringent social distancing (shielding) has had on a large cohort of rheumatology (RD) follow-up patients from a single large UK centre. Methods We linked COVID-19-re
Autor:
Margaret Timmons, Muhamad Jasim, Ute Pohl, Francesco Manfredonia, Hem Raj Sapkota, Nick Barkham
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3373-3377 (2020)
Clinical Case Reports
Clinical Case Reports
Statin‐induced autoimmune necrotizing myositis is a rare but important cause muscle weakness. Withdrawal of the statin and steroid treatment alone may be insufficient treatment for SIANM. Targeted immunosuppression may be needed and can be effectiv
Publikováno v:
Rheumatology. 60
Background/Aims Anti-neutrophil cytoplasmic antibody (ANCAs) associated vasculitis (AAV) encompasses: Granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). The 1999 internatio
Autor:
Natasha Cleaton, Hem Raj Sapkota, Nibha Jain, Girish Kakade, Aloka Gunawardane, Roshan I. Amarasena, Arumugam Moorthy, Nick Barkham, Ramasharan Laxminarayan, Tahir Khan
Publikováno v:
Rheumatology. 60
Background/Aims Secukinumab is an interleukin-17 inhibitor has been found to be effective in the treatment of ankylosing spondylitis (AS) in studies, including phase 3 clinical trials, however these are conducted in highly selected patients and it is
Publikováno v:
Rheumatology Advances in Practice
Objectives During the COVID-19 pandemic, face-to-face rheumatology follow-up appointments were mostly replaced with telephone or virtual consultations in order to protect vulnerable patients. We aimed to investigate the perspectives of rheumatology p